TrialJAMA cardiology2026

EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF.

Misato Chimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.